DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Atrasentan is an investigational drug.
There have been 19 clinical trials for Atrasentan. The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2001.
The most common disease conditions in clinical trials are Kidney Diseases, Prostatic Neoplasms, and Diabetic Nephropathies. The leading clinical trial sponsors are Abbott, National Cancer Institute (NCI), and AbbVie (prior sponsor, Abbott).
Recent Clinical Trials for Atrasentan
|Atrasentan in Patients With Proteinuric Glomerular Diseases||Chinook Therapeutics U.S., Inc.||Phase 2|
|Atrasentan in Patients With IgA Nephropathy||Chinook Therapeutics U.S., Inc.||Phase 3|
|Atrasentan Spermatogenesis and Testicular Function||AbbVie||Phase 2|